Endometrial cancer Clinical Trials
Recruiting endometrial cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat endometrial cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting endometrial cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting endometrial cancer trials
Signatera Assessment in Early-Stage Endometrial Cancer
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer
SL-28 for Advanced Solid Tumours
Study of EV for Recurrent Endometrial Carcinoma
SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer
Tirzepatide in the Treatment of Endometrial Cancer
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
Adaptive Radiotherapy for Safe Hypofractionation
Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4
Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy
MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer
QLS5132 Combination Therapy in Advanced Solid Tumors
Tirzepatide in Obesity-Driven Endometrial Cancer
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Fasting InTervention for Endometrial Cancer
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
The Use of a Novel Vaginal Speculum for Endometrial Biopsies
Preoperative Risk Stratification in Endometrial Cancer for Tailoring Lymph Node Staging
Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer
Distance-Based Exercise to Preserve Function and Prevent Disability
An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling Device
Cancer Loyalty Card Study 2 (CLOCS-2)
Intrauterine Injection of Type III Collage in FST of EC/AEH
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer
Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
REal Word aPpLicAtion of Molecular Based Endometrial Cancer Classification
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Endometrial cancer clinical trials — common questions
Are endometrial cancer clinical trials free to join?
Yes. Participating in a endometrial cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a endometrial cancer clinical trial?
Each endometrial cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a endometrial cancer trial near me?
Use the location controls above. We'll show recruiting endometrial cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many endometrial cancer trials are recruiting right now?
We're currently tracking roughly 122 recruiting endometrial cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.